BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 26609163)

  • 1. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
    Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
    J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study.
    Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A
    J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study.
    Blume T; Focke C; Peters F; Deussing M; Albert NL; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Ozmen L; Baumann K; Bartenstein P; Rominger A; Herms J; Brendel M
    J Neuroinflammation; 2018 Nov; 15(1):307. PubMed ID: 30400912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.
    Yang Z; Banks SJ; Ritter AR; Cummings JL; Sreenivasan K; Kinney JW; Caldwell JK; Wong CG; Miller JB; Cordes D
    J Alzheimers Dis; 2023; 96(4):1505-1514. PubMed ID: 37980664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein.
    Fan Z; Calsolaro V; Atkinson RA; Femminella GD; Waldman A; Buckley C; Trigg W; Brooks DJ; Hinz R; Edison P
    J Nucl Med; 2016 Nov; 57(11):1753-1759. PubMed ID: 27261523
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Chaney A; Cropper HC; Johnson EM; Lechtenberg KJ; Peterson TC; Stevens MY; Buckwalter MS; James ML
    J Nucl Med; 2019 Jan; 60(1):122-128. PubMed ID: 29976695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [
    Deussing M; Blume T; Vomacka L; Mahler C; Focke C; Todica A; Unterrainer M; Albert NL; Lindner S; von Ungern-Sternberg B; Baumann K; Zwergal A; Bartenstein P; Herms J; Rominger A; Brendel M
    Neuroimage; 2018 Jan; 165():83-91. PubMed ID: 28988133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
    Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer's disease using N-(2,5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl)acetamide.
    James ML; Belichenko NP; Nguyen TV; Andrews LE; Ding Z; Liu H; Bodapati D; Arksey N; Shen B; Cheng Z; Wyss-Coray T; Gambhir SS; Longo FM; Chin FT
    J Nucl Med; 2015 Feb; 56(2):311-6. PubMed ID: 25613536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Brackhan M; Bascuñana P; Ross TL; Bengel FM; Bankstahl JP; Bankstahl M
    Epilepsia; 2018 Mar; 59(3):617-626. PubMed ID: 29364511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Kim K; Kim H; Bae SH; Lee SY; Kim YH; Na J; Lee CH; Lee MS; Ko GB; Kim KY; Lee SH; Song IH; Cheon GJ; Kang KW; Kim SE; Chung JK; Kim EE; Paek SH; Lee JS; Lee BC; Youn H
    Theranostics; 2020; 10(20):9315-9331. PubMed ID: 32802194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
    Nack A; Brendel M; Nedelcu J; Daerr M; Nyamoya S; Beyer C; Focke C; Deussing M; Hoornaert C; Ponsaerts P; Schmitz C; Bartenstein P; Rominger A; Kipp M
    Cells; 2019 Jan; 8(2):. PubMed ID: 30696113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography.
    Rejc L; Gómez-Vallejo V; Joya A; Arsequell G; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Iglesias L; Capetillo-Zarate E; Ramos-Cabrer P; Martin A; Llop J
    Alzheimers Res Ther; 2022 Jun; 14(1):80. PubMed ID: 35676734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal
    Takkinen JS; López-Picón FR; Al Majidi R; Eskola O; Krzyczmonik A; Keller T; Löyttyniemi E; Solin O; Rinne JO; Haaparanta-Solin M
    J Cereb Blood Flow Metab; 2017 Aug; 37(8):2870-2882. PubMed ID: 27834284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease.
    López-Picón FR; Snellman A; Eskola O; Helin S; Solin O; Haaparanta-Solin M; Rinne JO
    J Nucl Med; 2018 Mar; 59(3):509-515. PubMed ID: 28986511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
    Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
    Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
    Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
    J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life Span of Wild-Type Mice: A PET Study.
    Brendel M; Focke C; Blume T; Peters F; Deussing M; Probst F; Jaworska A; Overhoff F; Albert N; Lindner S; von Ungern-Sternberg B; Bartenstein P; Haass C; Kleinberger G; Herms J; Rominger A
    J Nucl Med; 2017 Dec; 58(12):1984-1990. PubMed ID: 28705919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.